🔗 Permalink

Inventor profile of:

Robert D. Mass

City:

Mill Valley, California

Country:

United States

Published Applications:

Last publication date:

2023-07-13

Top Assignees for applications by Robert D. Mass

The entities that hold a legal rights for patent applications filed by inventor Mass Robert D.:

Genentech, Inc. 40 South San Francisco, CA United States
Genetech, Inc. 1 South San Francisco, CA United States

Recent patent applications by Mass Robert D.

Robert D. Mass from Mill Valley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-13

US20230218755A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#2 | 2021-01-21

US20210015918A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#3 | 2020-06-04

US20200171148A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#4 | 2019-10-10

US20190307881A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#5 | 2019-03-07

US20190070291A1

Human necessities

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN ErbB ANTAGONIST CANCER THERAPY

#6 | 2018-08-09

US20180221473A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#7 | 2018-07-26

US20180208647A1

Chemistry; metallurgy

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

#8 | 2017-12-21

US20170360928A1

Human necessities

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN ErbB ANTAGONIST CANCER THERAPY

#9 | 2016-04-21

US20160108116A1

Chemistry; metallurgy

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

#10 | 2015-06-04

US20150150970A1

Human necessities

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN ErbB ANTAGONIST CANCER THERAPY

#11 | 2014-09-04

US20140248609A1

Chemistry; metallurgy

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY

#12 | 2014-06-26

US20140178363A1

Human necessities

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

#13 | 2013-08-01

US20130195847A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#14 | 2013-01-31

US20130028862A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#15 | 2012-06-14

US20120148584A1

Chemistry; metallurgy

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE THREATMENT OF EARLY STAGE TUMORS

#16 | 2012-04-19

US20120093838A1

Human necessities

Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy

#17 | 2012-02-09

US20120034609A1

Human necessities

Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy

#18 | 2011-05-26

US20110123494A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#19 | 2011-03-03

US20110052576A1

Chemistry; metallurgy

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS

#20 | 2010-10-21

US20100266589A1

Chemistry; metallurgy

ADJUVANT CANCER THERAPY

#21 | 2010-09-09

US20100226880A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#22 | 2010-04-08

US20100086544A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING A NEOPLASM

#23 | 2009-10-01

US20090246173A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#24 | 2009-09-24

US20090239236A1

Human necessities

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY

#25 | 2009-07-30

US20090191215A1

Human necessities

Treatment with anti-VEGF Antibodies

#26 | 2009-02-26

US20090053216A1

Human necessities

Treatment with Anti-VEGF Antibodies

#27 | 2009-01-08

US20090010883A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#28 | 2008-11-27

US20080292631A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#29 | 2008-11-27

US20080292630A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#30 | 2008-11-13

US20080279860A1

Human necessities

Treatment With Anti-VEGF Antibodies

#31 | 2008-10-30

US20080267968A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#32 | 2008-10-09

US20080248049A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#33 | 2008-10-09

US20080248036A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#34 | 2008-10-09

US20080248033A1

Chemistry; metallurgy

VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors

#35 | 2008-10-02

US20080241148A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#36 | 2008-08-21

US20080199464A1

Human necessities

Combination Therapy with Angiogenesis Inhibitors

#37 | 2008-07-10

US20080166351A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#38 | 2008-07-03

US20080160029A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#39 | 2008-05-15

US20080112958A1

Human necessities

Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy

#40 | 2007-11-08

US20070258984A1

Human necessities

Treatment with anti-VEGF antibodies

#41 | 2007-08-30

US20070202516A1

Human necessities

GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY

#42 | 2007-07-19

US20070166753A1

Human necessities

Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy

#43 | 2007-07-12

US20070160608A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#44 | 2007-07-05

US20070154483A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#45 | 2007-06-28

US20070148178A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#46 | 2007-06-28

US20070148177A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#47 | 2007-03-29

US20070071749A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#48 | 2007-03-29

US20070071748A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#49 | 2007-03-29

US20070071718A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#50 | 2007-02-15

US20070036790A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#51 | 2007-02-15

US20070036753A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#52 | 2007-02-08

US20070031413A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#53 | 2007-02-01

US20070025999A1

Human necessities

TREATMENT WITH ANTI-VEGF ANTIBODIES

#54 | 2006-10-12

US20060228745A1

Human necessities

Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy

#55 | 2005-08-25

US20050186208A1

Human necessities

Treatment with anti-VEGF antibodies

InventorID:

65759 ⎘